About Astellas Pharma
Astellas Pharma Inc is an SEC registrant. It files with the SEC under Central Index Key 0001446390. Its most recent filing on EDGAR is an F-6EF, filed November 22, 2019. It reported about $2.9 million of federal lobbying in the four quarters through Q3 2026.
Across SEC filings
Federal lobbying · LD-2
$2.9M
reported spend, four quarters through Q3 2026
Loading SEC filings...
Loading sponsor profile...